NASDAQ:ALNY
Alnylam Pharmaceuticals, Inc.
- Stock
Last Close
150.31
03/05 20:00
Market Cap
22.54B
Beta: 0.48
Volume Today
440.18K
Avg: 846.05K
PE Ratio
−42.10
PFCF: −323.22
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -89.22M - | -360.39M 303.92% | -290.07M 19.51% | -410.11M 41.38% | -490.87M 19.69% | -761.50M 55.13% | -886.12M 16.37% | -858.28M 3.14% | -852.82M 0.64% | -1.13B 32.64% | -440.24M 61.08% | |
depreciation and amortization | 10.23M - | 11.93M 16.59% | 19.05M 59.74% | 15.13M 20.58% | 13.37M 11.65% | 6.43M 51.86% | 54.37M 744.88% | 74.44M 36.91% | 89.69M 20.50% | 85.55M 4.62% | 54.05M 36.82% | |
deferred income tax | -2.69M - | -42.29M 1,469.20% | -6.98M - | 1.89M 127.15% | -3.56M 288.17% | -11.29M 216.72% | -54.04M 378.76% | -55.70M 3.06% | -399.36M - | |||
stock based compensation | 20.70M - | 33.06M 59.69% | 45.78M 38.48% | 75.53M 64.97% | 92.82M 22.89% | 157.75M 69.96% | 174.84M 10.83% | 139.87M 20.00% | 165.72M 18.48% | 230.65M 39.18% | 221.68M 3.89% | |
change in working capital | -8.12M - | -29.40M 262.17% | 35.12M 219.44% | 17.22M 50.97% | -2.90M 116.85% | 45.10M 1,654.07% | 402.38M 792.22% | -12.70M 103.16% | -162.82M 1,181.97% | -35.55M 78.16% | 10.76M 130.26% | |
accounts receivables | -4.14M - | -35.69M 761.22% | 31.64M 188.65% | -15.04M 147.52% | -10.67M 29.05% | 15.24M 242.88% | -24.24M 259.02% | -56.24M 132.02% | -101.80M 81.02% | -45.60M 55.21% | -87.94M 92.86% | |
inventory | 191K - | 3.29M 1,624.08% | -477K 114.49% | 5.40M 1,231.45% | 10.86M 101.17% | -22.64M 308.58% | -32.41M 43.13% | -35.43M 9.30% | -26.41M 25.44% | -34.14M 29.23% | 18.37M 153.81% | |
accounts payables | 1.83M - | 8.84M 382.53% | 1.68M 81.04% | 10.10M 502.51% | -4.94M 148.91% | 15.48M 413.38% | 36.61M 136.52% | 117.38M 220.62% | 88.24M 24.82% | 191.77M 117.33% | 80.84M 57.85% | |
other working capital | -6.00M - | -5.84M 2.53% | 2.28M 138.97% | 16.76M 635.73% | 1.85M 88.97% | 37.02M 1,903.46% | 422.42M 1,040.94% | -38.41M 109.09% | -122.85M 219.79% | -147.59M 20.14% | -509K 99.66% | |
other non cash items | 449K - | 221.46M 49,222.49% | 984K 99.56% | 1.51M 53.15% | 2.91M 93.10% | -6.84M 335.09% | -12.61M 84.37% | 95.75M 859.18% | 174.24M 81.96% | 309.24M 77.48% | 657.26M 112.54% | |
net cash provided by operating activities | -68.66M - | -165.64M 141.26% | -189.14M 14.19% | -307.70M 62.68% | -382.79M 24.40% | -562.62M 46.98% | -278.43M 50.51% | -614.96M 120.87% | -641.69M 4.35% | -541.27M 15.65% | 104.16M 119.24% | |
investments in property plant and equipment | -4.01M - | -8.96M 123.69% | -12.95M 44.52% | -64.56M 398.51% | -104.21M 61.42% | -126.89M 21.76% | -140.16M 10.46% | -70.36M 49.80% | -76.37M 8.54% | -72.06M 5.65% | -62.21M 13.67% | |
acquisitions net | ||||||||||||
purchases of investments | -364.31M - | -977.77M 168.39% | -1.03B 5.73% | -759.31M 26.55% | -903.46M 18.98% | -1.10B 22.20% | -2.08B 88.03% | -2.03B 2.42% | -1.66B 18.24% | -1.98B 19.37% | -1.88B 4.80% | |
sales maturities of investments | 237.81M - | 462.92M 94.66% | 726.94M 57.03% | 1.12B 53.58% | 597.30M 46.50% | 1.52B 154.26% | 1.78B 16.90% | 1.69B 4.72% | 1.46B 13.48% | 2.23B 52.48% | 1.61B 27.75% | |
other investing activites | -25M - | -1.47M 94.12% | -150M 10,097.14% | 120M 180% | -14.82M 112.35% | 23M 255.14% | -31.20M 235.65% | -4.36M 86.01% | -13.19M 202.34% | -4.44M 66.36% | ||
net cash used for investing activites | -130.50M - | -548.81M 320.53% | -321.32M 41.45% | 142.59M 144.38% | -290.36M 303.63% | 272.94M 194.00% | -417.68M 253.03% | -435.52M 4.27% | -273.30M 37.25% | 169.35M 161.97% | -336.35M 298.61% | |
debt repayment | -120M - | -30M - | -686.60M 2,188.66% | -1B 45.65% | -762.11M 23.79% | |||||||
common stock issued | 173.57M - | 723.04M 316.56% | 585.42M 19.03% | 14.30M 97.56% | 1.16B 8,018.36% | 781.90M - | 99.50M 87.27% | 246.27M 147.51% | 259.36M 5.32% | 147.46M 43.14% | ||
common stock repurchased | -1.39M - | -15.99M 1,051.33% | -378K 97.64% | -596K 57.67% | -257K 56.88% | -3.47M 1,249.81% | ||||||
dividends paid | ||||||||||||
other financing activites | 28.74M - | 29.42M 2.36% | 31.14M 5.84% | 164.13M 427.11% | 84.14M 48.73% | 68.94M 18.07% | 71.28M 3.40% | 1.58B 2,119.40% | 2.00B 26.47% | 928.50M 53.59% | 24.67M 97.34% | |
net cash used provided by financing activities | 200.93M - | 736.47M 266.54% | 616.18M 16.33% | 177.83M 71.14% | 1.12B 532.56% | 65.47M 94.18% | 823.18M 1,157.35% | 994.98M 20.87% | 1.25B 25.34% | 425.75M 65.86% | 172.13M 59.57% | |
effect of forex changes on cash | -83K - | 4.92M 6,025.30% | -9.02M 283.37% | -7.43M 17.61% | 6.39M 186.02% | |||||||
net change in cash | 1.76M - | 22.01M 1,147.73% | 105.72M 380.31% | 12.72M 87.97% | 451.74M 3,450.89% | -224.20M 149.63% | 127.00M 156.64% | -50.58M 139.83% | 323.11M 738.78% | 46.40M 85.64% | -53.71M 215.74% | |
cash at beginning of period | 51.41M - | 53.17M 3.43% | 75.18M 41.40% | 180.90M 140.62% | 193.62M 7.03% | 646.83M 234.08% | 422.63M 34.66% | 549.63M 30.05% | 499.05M 9.20% | 822.15M 64.74% | 866.39M 5.38% | |
cash at end of period | 53.17M - | 75.18M 41.40% | 180.90M 140.62% | 193.62M 7.03% | 645.36M 233.32% | 422.63M 34.51% | 549.63M 30.05% | 499.05M 9.20% | 822.15M 64.74% | 868.56M 5.64% | 812.69M 6.43% | |
operating cash flow | -68.66M - | -165.64M 141.26% | -189.14M 14.19% | -307.70M 62.68% | -382.79M 24.40% | -562.62M 46.98% | -278.43M 50.51% | -614.96M 120.87% | -641.69M 4.35% | -541.27M 15.65% | 104.16M 119.24% | |
capital expenditure | -4.01M - | -8.96M 123.69% | -12.95M 44.52% | -64.56M 398.51% | -104.21M 61.42% | -126.89M 21.76% | -140.16M 10.46% | -70.36M 49.80% | -76.37M 8.54% | -72.06M 5.65% | -62.21M 13.67% | |
free cash flow | -72.66M - | -174.60M 140.29% | -202.09M 15.74% | -372.26M 84.20% | -487.00M 30.82% | -689.50M 41.58% | -418.58M 39.29% | -685.32M 63.72% | -718.07M 4.78% | -613.33M 14.59% | 41.95M 106.84% |
All numbers in USD (except ratios and percentages)